NephroDI Therapeutics, Inc. is a clinical-stage pharmaceutical and biotechnology company focused on developing specialized therapeutics. The company is headquartered in Seattle, Washington, United States.
Subscribe to see NephroDI Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
NephroDI Therapeutics, Inc. is a biotechnology company headquartered in Seattle, United States. It has raised at least $3.6M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $2M in June 2024. Xcout tracks 7 named people at NephroDI Therapeutics, Inc., including Rachael Hagan (President).
As of 17 November 2026. Source: Xcout Intel.
1 more named person on record for NephroDI Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
At least $3.6M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $2M | 2 named | |
| SEC Form D filing | $1.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of NephroDI Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Kanjin Therapeutics is a biotechnology startup headquartered in Wilmington, Delaware, with operations spanning the United States and Japan. Founded in 2025, the company focuses on pioneering medical interventions to restore kidney function and transform the treatment of chronic kidney diseases.
InduPro is a biotechnology company focused on advanced science and proximity-based therapeutics that bring cell surface proteins together for novel drug designs. The company is headquartered in Seattle, Washington.
Goldfinch Bio, Inc. is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing precision medicines for the treatment of kidney diseases.
Nephrogen is a preclinical biotechnology company founded in 2022 and headquartered in New York, NY. The company is dedicated to developing curative genomic medicines for patients suffering from serious diseases.
Umoja Biopharma is a biotechnology research company headquartered in Seattle, Washington, focused on developing next-generation immunotherapies.
MDI Therapeutics, Inc. is a pharmaceutical company headquartered in Novi, Michigan. The company specializes in researching and developing novel therapeutics for the treatment of fibrosis and related fibrotic diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about NephroDI Therapeutics, Inc.? Suggest a correction · Work at NephroDI Therapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.